  | Poleur, M., Gidaro, T., DELSTANCHE, S., Gurruchaga, J.-M., Tricot, A., Bancel, L., Palfi, S., Servais, L., & Degos, B. (27 November 2025). Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment. Scientific Reports, 15 (1), 45479. doi:10.1038/s41598-025-28927-1  Peer Reviewed verified by ORBi |
 | Mouraux, C., Dangouloff, T., Poleur, M., Mackels, L., Vanden Brande, L., Daron, A., Servais, L., Maertens de Noordhout, A., & DELSTANCHE, S. (29 August 2025). Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium. Orphanet Journal of Rare Diseases, 20 (1), 464. doi:10.1186/s13023-025-03963-2 Peer Reviewed verified by ORBi |
 | DELSTANCHE, S., Claeys, K. G., De Bleecker, Remiche, G., Troisfontaines, P., Van Parys, V., & Bondue, A. (December 2024). Phenotype variability and therapeutic response to Patisiran in patients with hereditary transthyretin amyloidosis: a Belgian real-world experience. Acta Clinica Belgica, 79 (6), 393 - 402. doi:10.1080/17843286.2025.2464971 Peer Reviewed verified by ORBi |
 | De Bleecker, J. L., Remiche, G., Alonso-Jiménez, A., Van Parys, V., Bissay, V., DELSTANCHE, S., & Claeys, K. G. (August 2024). Recommendations for the management of myasthenia gravis in Belgium. Acta Neurologica Belgica, 124 (4), 1371 - 1383. doi:10.1007/s13760-024-02552-7 Peer Reviewed verified by ORBi |
 | Poleur, M., Nemr, A., Bancel, L., Parinello, G., Cluzeau, C., Bechichi, Y., DELSTANCHE, S., & Servais, L. (09 April 2024). Digital Outcome Measure Assessing the Motor Function of Patients with Amyotrophic Lateral Sclerosis (P5-11.011) [Poster presentation]. American Academy of Neurology. doi:10.1212/wnl.0000000000205650 Peer reviewed |
  | Dangouloff, T., Thokala, P., Stevenson, M. D., Deconinck, N., D'Amico, A., Daron, A., DELSTANCHE, S., Servais, L., & Hiligsmann, M. (02 January 2024). Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium. Neuromuscular Disorders, 34, 61-67. doi:10.1016/j.nmd.2023.11.013 Editorial reviewed |
 | Mouraux, C., Dangouloff, T., Poleur, M., Mackels, L., Vanden Brande, L., Daron, A., Servais, L., Maertens de Noordhout, A., & DELSTANCHE, S. (2024). Epidemiological study and diagnostic approach analysis of Neuromuscular population of Neuromuscular Reference Center of Liege, Belgium [Poster presentation]. BeSHG annual symposium 2024, Belgium. Peer reviewed |
 | De Bleecker, J. L., Claeys, K. G., DELSTANCHE, S., Van Parys, V., Baets, J., Tilleux, S., & Remiche, G. (June 2023). A retrospective survey of patients with hereditary transthyretin-mediated (hATTR) amyloidosis treated with patisiran in real-world clinical practice in Belgium. Acta Neurologica Belgica, 123 (3), 1029 - 1037. doi:10.1007/s13760-023-02188-z Peer Reviewed verified by ORBi |
 | Poleur, M., Maertens De Noordhout, A., Lievens, I., & Delstanche, S. (2023). Overview of Patients With Chronic Inflammatory Demyelinating Polyneuropathy of the Neuromuscular Reference Center of Liège. Journal of Neuromuscular Diseases. Peer Reviewed verified by ORBi |
 | Thibaut, A., Beaudart, C., QUINET, M., BOUQUIAUX, O., DELSTANCHE, S., LIEVENS, I., Grosjean, D., Ortmans, I., Kaux, J.-F., & Halleux, C. (February 2022). Prise en charge psychologique et cognitive au cours de l’accompagnement de fin de vie de patients atteints de sclérose latérale amyotrophique. Une revue systématique. Revue Médicale de Liège, 77 (2), 104-109. Peer reviewed |
 | Poleur, M., Annoussamy, M., Clavel, L., Buscemi, L., DELSTANCHE, S., Eggenspieler, D., Maertens De Noordhout, A., Bouquiaux, O., Lievens, I., & Servais, L. (2022). Wearable inertial sensors for longitudinal follow-up of patients with amyotrophic lateral sclerosis. Nervno-Myšečnye Bolezni. Peer Reviewed verified by ORBi |
 | Hustinx, M., Poleur, M., Daron, A., Maertens De Noordhout, A., Servais, L., & Delstanche, S. (2022). Overlap Between Hereditary Sensory- Motor Neuropathy (HSMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Journal of Neuromuscular Diseases. Peer Reviewed verified by ORBi |
 | Poleur, M., Annoussamy, M., Eggenspieler, D., DELSTANCHE, S., DARON, A., & Servais, L. (October 2021). Longitudinal follow-up of adult patients with spinal muscular atrophy undergoing nusinersen treatment using an innovative magneto-inertial device. Neuromuscular Disorders, 31, 130. doi:10.1016/j.nmd.2021.07.290 Peer Reviewed verified by ORBi |
 | Grapperon, A.-M., Verschueren, A., Jouve, E., Morizot-Koutlidis, R., Lenglet, T., Pradat, P.-F., Salachas, F., Bernaard, E., Delstanche, S., MAERTENS de NOORDHOUT, A., Guy, N., Danel, V., Delval, A., Delmont, E., Rolland, A.-S., PULSE Study Group, Jomir, L., Devos, D., WANG, F.-C., & Attarian, S. (2021). Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study. Clinical Neurophysiology. doi:10.1016/j.clinph.2021.08.003 Peer Reviewed verified by ORBi |
 | Vanherpe, P., Fieuws, S., D'Hondt, A., Bleyenheuft, C., Demaerel, P., De Bleecker, J., Van den Bergh, P., Baets, J., Remiche, G., Verhoeven, K., DELSTANCHE, S., Toussaint, M., Buyse, B., Van Damme, P., Depuydt, C. E., & Claeys, K. G. (05 April 2020). Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures. Orphanet Journal of Rare Diseases, 15 (1), 83. doi:10.1186/s13023-020-01353-4 Peer Reviewed verified by ORBi |
 | Sansone, V. A., Walter, M. C., Attarian, S., DELSTANCHE, S., Mercuri, E., Lochmüller, H., Neuwirth, C., Vazquez-Costa, J. F., Kleinschnitz, C., & Hagenacker, T. (2020). Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report. Journal of Neuromuscular Diseases, 7 (4), 523 - 534. doi:10.3233/JND-200534 Peer Reviewed verified by ORBi |
 | Daron, A., DELSTANCHE, S., Dangouloff, T., & Servais, L. (February 2019). Amyotrophie spinale infantile (R)évolution thérapeutique. Revue Médicale de Liège, 74 (2), 82-85. |
 | DELSTANCHE, S., Servais, L., & Gidaro, T. (March 2017). Improved Muscular Weakness During Asthma Exacerbation. JAMA Neurology, 74 (3), 353-354. doi:10.1001/jamaneurol.2016.4069 Peer Reviewed verified by ORBi |
| SALADO, A.-L., Scholtes, F., DELSTANCHE, S., FUMAL, A., PEPIN, J.-L., & MAERTENS DE NOORDHOUT, A. (2014). Neurosurgery and Spontaneous Intracranial Hypotension [Poster presentation]. BSN 2014. |
 | DELSTANCHE, S., Deflandre, T., Otto, B., TSHIBANDA, L., SIMONI, P., & Moonen, G. (13 June 2013). La xanthomatose cérébro-tendineuse, une maladie métabolique rare, grave mais curable. Revue Médicale de Liège, 68 (4), 171-6. Peer reviewed |
 | Chaballe, L., Close, P., SEMPELS, M., DELSTANCHE, S., FANIELLE, J., Moons, L., Carmeliet, P., Schoenen, J., Chariot, A., & Franzen, R. (March 2011). Involvement of placental growth factor in Wallerian degeneration. Glia, 59 (3), 379-396. doi:10.1002/glia.21108 Peer Reviewed verified by ORBi |
| Chaballe, L., Close, P., Sempels, M., Delstanche, S., Fanielle, J., Moons, L., Carmeliet, P., Schoenen, J., Chariot, A., & Franzen, R. (September 2010). Involvement of Placental growth factor in Wallerian degeneration [Poster presentation]. Belgian Brain Congress, Bruxelles, Belgium. |
 | DELSTANCHE, S., & Schoenen, J. (2010). Botulinum toxin for the treatment of headache:a promising path on a “dead end road”? Acta Neurologica Belgica, 110, 221-229. Peer Reviewed verified by ORBi |
| Chaballe, L., Delstanche, S., Wouters, M., Moons, L., Carmeliet, P., Schoenen, J., & Franzen, R. (07 May 2007). Role of Placental Growth Factor (PLGF) in the inflammatory context resulting from nerve injury, the Wallerian Degeneration [Poster presentation]. Belgian Society for Neurosciences, Antwerpen, Belgium. |
| DELSTANCHE, S., & Schoenen, J. (2006). La toxine botulinique dans le traitement des céphalées. Revue Médicale de Liège, 11, 148-154. Peer reviewed |
